In synovial sarcoma, patients with higher CD8+ or FOXP3+ lymphocyte infiltration were associated with good overall survival, whereas patients with higher CD163+ macrophage infiltration had significantly lower overall and progression-free survival [47]. The gene discussed is CD8A; the disease is synovial sarcoma.